Patrick Tippoo on Vaccine Development and Production in Africa │Mission Imagination
Less than 1% of vaccines used in Africa are manufactured locally, but the need for immunization continues to grow. How can we ramp up vaccine manufacturing in the continent? And what role does intellectual property play in vaccine development, production and supply?
The eighth episode of WIPO’s Mission Imagination series features Patrick Tippoo, Chief Science and Innovation Officer at South Africa-based Biovac, and Executive Director and founding member of the African Vaccine Manufacturing Initiative (AVMI), who shares insights on what it takes to build sustainable vaccine manufacturing ecosystems.
In conversation with Amy Dietterich, Director of WIPO’s Global Challenges Division, Patrick explains what’s required to successfully continue Africa’s vaccine manufacturing journey, the importance of knowledge transfer partnerships, and what we can expect from Biovac’s oral cholera vaccine deal.
Subscribe to our channel for more episodes of Mission Imagination – conversations with creative, innovative people from across the globe who are working to improve our world.
#WIPO